unauthorized
Iron
- Joined
- Feb 10, 2026
- Posts
- 26
- Reputation
- 17
Found a source for both. But TYRA-300 i way more expensive for the same period of usage
some guy on the internet tells me that tyra is better in all regards
But based on published data:
Question: For the sole goal of maximizing height by inhibiting FGFR3, why would I pay 10x more for a less potent, "safer" drug? What am I missing? Would you still pay for the safety profile if you didn't care about it? Like i don't really want to mess up my metabolic processes related to phosphorus and potentially go blind, is it really that serious, like is risks really that high if i will run erda approximately 1 year straight? or should i just buy TYRA?
some guy on the internet tells me that tyra is better in all regards
But based on published data:
- Erdafitinib: FGFR3 IC50 = 3.0 nM (enzymatic assay)
- TYRA-300: FGFR3 IC50 = 11 nM (Ba/F3 cells)
Question: For the sole goal of maximizing height by inhibiting FGFR3, why would I pay 10x more for a less potent, "safer" drug? What am I missing? Would you still pay for the safety profile if you didn't care about it? Like i don't really want to mess up my metabolic processes related to phosphorus and potentially go blind, is it really that serious, like is risks really that high if i will run erda approximately 1 year straight? or should i just buy TYRA?

